Number 1 Peptide mass (mg) This is the amount of peptide in the vial, printed on the label: 5 mg, 10 mg, 15 mg, and so on
We can't stress this enough: consistency during this phase is paramount
RELATED: Retatrutide, Eli Lilly's next obesity drug, fueled dramatic weight loss in clinical trial To qualify, besides having Medicare drug coverage, you must have a body mass index of 35 or higher, or a BMI of 27 or higher alongside another health condition, such as a past heart attack or stroke, prediabetes or another from a list on the CMS website
The future landscape: Beyond weight management The use of transdermal delivery systems is not restricted to diabetes management and weight loss in patients with obesity
Type 2 diabetes affects over 500 million people worldwide, and obesity affects more than 890 million